209 related articles for article (PubMed ID: 31228750)
21. A D2 dopamine receptor agonist disrupts sensorimotor gating in rats. Implications for dopaminergic abnormalities in schizophrenia.
Peng RY; Mansbach RS; Braff DL; Geyer MA
Neuropsychopharmacology; 1990 Jun; 3(3):211-8. PubMed ID: 2141986
[TBL] [Abstract][Full Text] [Related]
22. The substantia nigra pars reticulata mediates the enhancement of startle by the dopamine D1 receptor agonist SKF 82958 in rats.
Meloni EG; Davis M
Psychopharmacology (Berl); 2004 Jul; 174(2):228-36. PubMed ID: 14735289
[TBL] [Abstract][Full Text] [Related]
23. Comparing the effects of 17β-oestradiol and the selective oestrogen receptor modulators, raloxifene and tamoxifen, on prepulse inhibition in female rats.
Gogos A; van den Buuse M
Schizophr Res; 2015 Nov; 168(3):634-9. PubMed ID: 25979306
[TBL] [Abstract][Full Text] [Related]
24. Dopamine Receptor Blockade Attenuates Purinergic P2X4 Receptor-Mediated Prepulse Inhibition Deficits and Underlying Molecular Mechanisms.
Khoja S; Asatryan L; Jakowec MW; Davies DL
Front Cell Neurosci; 2019; 13():331. PubMed ID: 31396053
[TBL] [Abstract][Full Text] [Related]
25. GPR88 in A
Meirsman AC; de Kerchove d'Exaerde A; Kieffer BL; Ouagazzal AM
Eur J Neurosci; 2017 Aug; 46(4):2026-2034. PubMed ID: 28700108
[TBL] [Abstract][Full Text] [Related]
26. Neonatal quinpirole treatment produces prepulse inhibition deficits in adult male and female rats.
Maple AM; Smith KJ; Perna MK; Brown RW
Pharmacol Biochem Behav; 2015 Oct; 137():93-100. PubMed ID: 26296939
[TBL] [Abstract][Full Text] [Related]
27. Progestins' actions in the VTA to facilitate lordosis involve dopamine-like type 1 and 2 receptors.
Frye CA; Walf AA; Sumida K
Pharmacol Biochem Behav; 2004 Jul; 78(3):405-18. PubMed ID: 15251249
[TBL] [Abstract][Full Text] [Related]
28. Contributions of dopamine D1, D2, and D3 receptor subtypes to the disruptive effects of cocaine on prepulse inhibition in mice.
Doherty JM; Masten VL; Powell SB; Ralph RJ; Klamer D; Low MJ; Geyer MA
Neuropsychopharmacology; 2008 Oct; 33(11):2648-56. PubMed ID: 18075489
[TBL] [Abstract][Full Text] [Related]
29. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
LaHoste GJ; Marshall JF
Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
[TBL] [Abstract][Full Text] [Related]
30. Dopamine receptor activation in bovine pinealocyte via a cAMP-dependent transcription pathway.
Santanavanich C; Ebadi M; Govitrapong P
J Pineal Res; 2005 Apr; 38(3):170-5. PubMed ID: 15725338
[TBL] [Abstract][Full Text] [Related]
31. Role of dopamine D1 and D2 receptors in the nucleus accumbens in mediating reward.
Ikemoto S; Glazier BS; Murphy JM; McBride WJ
J Neurosci; 1997 Nov; 17(21):8580-7. PubMed ID: 9334429
[TBL] [Abstract][Full Text] [Related]
32. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
Hu XT; White FJ
Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
[TBL] [Abstract][Full Text] [Related]
33. Histamine H
Aquino-Miranda G; Rivera-Ramírez N; Márquez-Gómez R; Escamilla-Sánchez J; González-Pantoja R; Ramos-Languren LE; Perez-Neri I; Bueno-Nava A; Ríos C; Arias-Montaño JA
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Aug; 94():109653. PubMed ID: 31108178
[TBL] [Abstract][Full Text] [Related]
34. Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding.
Engber TM; Marin C; Susel Z; Chase TN
Eur J Pharmacol; 1993 Jun; 236(3):385-93. PubMed ID: 8102970
[TBL] [Abstract][Full Text] [Related]
35. Role of dopamine in prepulse inhibition of acoustic startle.
Zhang J; Forkstam C; Engel JA; Svensson L
Psychopharmacology (Berl); 2000 Apr; 149(2):181-8. PubMed ID: 10805614
[TBL] [Abstract][Full Text] [Related]
36. The adenosine A(2A) receptor agonist CGS 21680 alleviates auditory sensorimotor gating deficits and increases in accumbal CREB in rats neonatally treated with quinpirole.
Brown RW; Bhide PG; Gill WD; Peeters LD
Psychopharmacology (Berl); 2020 Dec; 237(12):3519-3527. PubMed ID: 32772144
[TBL] [Abstract][Full Text] [Related]
37. Differential regulation of release of acetylcholine in the striatum in mice following continuous exposure to selective D1 and D2 dopaminergic agonists.
Wang HY; Zhou LW; Friedman E; Weiss B
Neuropharmacology; 1993 Jan; 32(1):85-91. PubMed ID: 8094235
[TBL] [Abstract][Full Text] [Related]
38. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
Wachtel SR; Hu XT; Galloway MP; White FJ
Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
[TBL] [Abstract][Full Text] [Related]
39. The Neurosteroidogenic Enzyme 5α-Reductase Mediates Psychotic-Like Complications of Sleep Deprivation.
Frau R; Bini V; Soggiu A; Scheggi S; Pardu A; Fanni S; Roncada P; Puligheddu M; Marrosu F; Caruso D; Devoto P; Bortolato M
Neuropsychopharmacology; 2017 Oct; 42(11):2196-2205. PubMed ID: 28102229
[TBL] [Abstract][Full Text] [Related]
40. Sensorimotor gating in neurotensin-1 receptor null mice.
Feifel D; Pang Z; Shilling PD; Melendez G; Schreiber R; Button D
Neuropharmacology; 2010 Jan; 58(1):173-8. PubMed ID: 19596359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
